Patents by Inventor Fahkreddin Jamali

Fahkreddin Jamali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucosamine pro-drug
    Patent number: 8772227
    Abstract: To develop glucosamine (GlcN) pro-drugs with properties superior to the presently available GlcN products, we have synthesized derivatives with improved pharmaceutical properties. The synthesized derivatives include peptide-GlcN ester and amide conjugates where the peptide portion consists of one or more amino acids. One such compound is (5-amino-3,4,6-trihydroxyoxan-2-yl)methyl 2-(2-aminoacetamido)-3-methylbutanoate or glycine-valine-COO-GlcN (GV-GlcN).7.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: July 8, 2014
    Inventors: Fahkreddin Jamali, Kamalijit Kaur, Mohammadhossien Gilzad
  • Glucosamine Pro-drug
    Publication number: 20130196897
    Abstract: To develop glucosamine (GlcN) pro-drugs with properties superior to the presently available GlcN products, we have synthesized derivatives with improved pharmaceutical properties. The synthesized derivatives include peptide-GlcN ester and amide conjugates where the peptide portion consists of one or more amino acids. One such compound is (5-amino-3,4,6-trihydroxyoxan-2-yl)methyl 2-(2-aminoacetamido)-3-methylbutanoate or glycine-valine-COO-GlcN (GV-GlcN).
    Type: Application
    Filed: September 19, 2012
    Publication date: August 1, 2013
    Inventors: Fahkreddin Jamali, Kamalijit Kaur, Mohammadhossien Gilzad
  • Nsaid Compositions
    Publication number: 20080255104
    Abstract: The invention is directed to a composition and method for treating acute pain using a composition comprising one or more NSAID's, a metasilicate and optionally a fatty acid ester resulting in increased absorption of poorly soluble active NSAID's and increased absorption in suppressed vagal systems. The preferred composition comprises meloxicam on a metasilicate matrix; and one or more of the following: sodium bicarbonate, Gelucire®, and tartaric acid.
    Type: Application
    Filed: May 4, 2005
    Publication date: October 16, 2008
    Applicant: EQUITECH CORPORATION
    Inventors: Fahkreddin Jamali, Aghazadeh Habashi
  • NSAIDs compositions containing tartaric acid
    Publication number: 20050249808
    Abstract: The invention is a composition and method for treating acute pain using a composition containing one or more NSAIDs.
    Type: Application
    Filed: May 2, 2005
    Publication date: November 10, 2005
    Inventor: Fahkreddin Jamali
  • NSAIDs composition containing tartaric acid
    Publication number: 20030026834
    Abstract: The invention is a composition and method for treating acute pain using a composition containing one or more NSAIDs. The preferred composition includes ibuprofen, sodium bicarbonate, Gelucire, and tartaric acid.
    Type: Application
    Filed: June 11, 2002
    Publication date: February 6, 2003
    Inventor: Fahkreddin Jamali
  • Compositions for enhanced absorption of NSAIDs
    Publication number: 20030008003
    Abstract: The invention is a composition and method for treating acute pain using a composition containing one or more NSAIDs. The preferred composition includes ibuprofen, sodium bicarbonate, and Gelucire.
    Type: Application
    Filed: April 10, 2002
    Publication date: January 9, 2003
    Inventor: Fahkreddin Jamali
  • Animal model for evaluating analgesics
    Publication number: 20020192161
    Abstract: The invention is an animal model for testing the effectiveness of analgesics, such as NSAID, formulations or any other medicament administered for acute pain or trauma.
    Type: Application
    Filed: April 10, 2002
    Publication date: December 19, 2002
    Inventor: Fahkreddin Jamali